Pyridostygmine Flashcards
class
reversal; anticholinesterase
structure
quaternary ammonia
does not cross BBB
mech of action
covalently binds to the carbamyl group of the acetylcholinesterases, inhibiting the breakdown of ACh in the NMJ and increasing the availability of ACh at the motor end plate
LS
Vd
LS: low
Vd: 1 L/kg
active metabolite
none
elimination
70-90% excreted by kidneys;
25% metabolized by hepatic microsomal enzyme system
side effects
decreased SVR, BP, HR
bronchoconstriction
increased saliva, gastric secretions
contraindications
renal failure with increased doa
GI/GU obstruction
asthma
use with caution in CAD
onset
DOA
T1/2
onset: 16 min
DOA: 75 min
T1/2: 112 min
dose
100-300 mcg/kg
administer with glyco 0.01 mg/kg
PO 60 mg